AVE 20.0% 0.3¢ avecho biotechnology limited

deep-pocketed pharma giants poised to boost m&, page-2

  1. 5,330 Posts.
    lightbulb Created with Sketch. 32
    Hi moosey,

    I thought these presentations would be quite appropriate posted under this thread title - good viewing for all invested in this field of science.

    For the POHsters here who don't have time to watch all 3 presentations, Deutche Bank's Drug Delivery expert, Mr Steinberg assesses the market for Pain drugs at the beginning of the second presentation below (Part 2) - enjoy.

    This presentation is from the 2013 Drug Delivery Partnerships Conference and is presented by David Steinberg, Managing Director, Equity Research, Drug Delivery, at Deutche Bank in New. David discusses the current drug delivery environment and elaborates on some of the key trends that have been shaping the industry of late. He also offers some predictions for the drug delivery sector over the next few years.

    Drug Delivery in 2013 - Part 1


    Drug Delivery in 2013 - Part 2

    ____________________

    The following presentation which also comes from the 2013 Drug Delivery Partnerships Conference is a panel discussion between, Roy Waldron, Senior Vice President at PFIZER, Christopher Seaton, Senior Vice President ay BAYER PHARMACEUTICALS, James Hattersley, Vice President of SUN PHARMACEUTICALS, and Chris Jones, Vice President of ASTRAZENECA.

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(20.0%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $33 10.94K

Buyers (Bids)

No. Vol. Price($)
62 99962608 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 53831289 11
View Market Depth
Last trade - 13.14pm 17/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.